Expression of the invasive phenotype by MCF-7 human breast cancer cells transfected to overexpress protein kinase C-α or the erbB2 proto-oncogene

International Journal of Oncology

Volumn 10, Issue 1, 1997, Pages 71-76

  Connolly, Jeanne M ^a   Rose, David P ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Breast cancer; erbB2; Invasion; MCF 7; Proteases; Protein kinase C; Proto oncogene

Indexed keywords

METALLOPROTEINASE; PROTEIN KINASE C; UROKINASE;

ARTICLE; BREAST CANCER; CANCER INVASION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ONCOGENE C ERB; PRIORITY JOURNAL;

EID: 0031017630     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Stracke ML and Liotta LA: Multi-step cascade of tumor cell metastasis. In Vivo 6: 309-316, 1992.
2. Stetler-Stevenson WG: Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9: 289-303, 1990.
3. Kwaan HC: The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev 11: 291-311, 1992.
4. Nishizuka Y: The molecular heterogeneity of protein kinase C and its implication for cellular regulation. Nature 334: 661-665, 1988.
5. Palmantier R, Roberts JD, Glasgow WC, Eling TE and Olden K: Regulation of the adhesion of a human breast carcinoma cell line to type IV collagen and vitronectin: roles for lipoxygenase and protein kinase C. Cancer Res 56: 2206-2212, 1996.
6. Juarez J, Clayman G, Nakajima M, Tanabe KK, Saya H, Nicholson GL and Boyd D: Role and regulation of expression of 92 kDa type IV collagenase (MMP-9) in 2 invasive squamous cell carcinoma cell lines of the oral cavity. Int J Cancer 55: 10-18, 1993.
7. Honn KV, Timár J, Rozhin J, Bazaz R, Sameni M, Ziegler G and Sloan BF: A lipoxygenase metabolite, 12(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells. Exp Cell Res 214: 120-130, 1994.
8. Fabbro D, Kung W, Roos W, Regazzi R and Eppenberger U: Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship. Cancer Res 46: 2720-2725, 1986.
9. +-dependent protein kinase of human mammary carcinoma cells: inverse relationship to estrogen receptors. Int J Cancer 40: 344-348, 1987.
10. Thompson EW, Reich R, Shima TB, Albini A, Graf J, Martin GR, Dickson RB and Lippman ME: Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens. Cancer Res 48: 6764-6768, 1988.
11. Popowicz P, Engel G, Wilking N and Linder S: Differential effects of fibroblast co-culture on MCF-7 and MDA-MB-231 breast carcinoma cell invasion through Matrigel. Oncol Rep 2: 303-306, 1995.
12. Ozello L and Sordat M: Behavior of tumors produced by transplantation of human mammary cell lines in athymic nude mice. Eur J Cancer 16: 553-559, 1980.
13. Price JM and Zang RD: Studies of human breast cancer metastasis using nude mice. Cancer Metastasis Rev 8: 285-297, 1989/1990.
14. Ways DK, Kukoly CA, De Vente J, Hooker JL, Bryant WO, Posekany KJ, Fletcher DJ, Cook PP and Parker PJ: MCF-7 breast cancer cells transfected with protein kinase C-α exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J Clin Invest 95: 1906-1915, 1995.
15. Liu B, Maher RJ, Hannun YA, Porter AT and Honn KV: 12(S)-HETE enhancement of prostate tumor cell invasion: selective role of PKC-α. J Natl Cancer Inst 86: 1145-1151, 1994.
16. Yu D and Hung MC: Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells. Oncogene 6: 1991-1996, 1991.
17. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD and Muller WJ: Expression of the neu proto-oncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89: 10578-10582, 1992.
18. Yu D, Wang S-S, Dulski KM, Tsai C-M, Nicolson GL and Hung M-C: c-erbB2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res 54: 3260-3266, 1994.
19. Gum R, Wang S-W, Lengyel E, Yu D, Hung M-C, Juarez J and Boyd D: Up-regulation of urokinase-type plasminogen activator expression by the HER-2/neu proto-oncogene. Anticancer Res 15: 1167-1172, 1995.
20. Benz CC, Scott GK, Sarup JC, Johnson RM, Tripathy D, Coronado E, Shepard HM and Osborne CK: Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER-2/neu. Breast Cancer Res Treat 24: 85-95, 1992.
21. Cubellis MV, Wun TC and Blasi F: Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J 9: 1079-1085, 1990.
22. Clarke R, Brünner N, Thompson EW, Glanz P, Katz D, Dickson RB and Lippman ME: The inter-relationships between ovarian-independent growth, antiestrogen resistance and invasiveness in the malignant progression of human breast cancer. J Endocrinol 122: 331-340, 1989.
23. Liu X-H, Connolly JM and Rose DP: Eicosanoids as mediators of linoleic acid-stimulated invasion and type IV collagenase production by a metastatic human breast cancer cell line. Clin Exp Metastasis 14: 145-152, 1996.
24. Rønne E, Høyer-Hansen G, Brünner N, Pedersen H, Rank F, Osborne CK, Clark GM, Danø K and Grøndahl-Hansen J: Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunoabsorbent assay with a combination of mono-and polyclonal antibodies. Breast Cancer Res Treat 33: 199-207, 1995.
25. Long BJ and Rose DP: Invasive capacity and regulation of urokinase-type plasminogen activator in estrogen receptor (ER)-negative MDA-MB-231 human breast cancer cells, and a transfectant (S30) stably expressing ER. Cancer Lett 99: 209-215, 1996.
26. Thompson EW, Brünner N, Torn J, Johnson MD, Boulay V, Wright A, Lippman ME, Steeg PS and Clarke R: The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells. Clin Exp Metastasis 11: 15-26, 1993.
27. Sommers CL, Byers SW, Thompson EW, Torri JA and Gelmann EP: Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 31: 325-335, 1994.
28. Testa JE and Quigley JP: The role of urokinase-type plasminogen activator in aggressive tumor cell behavior. Cancer Metastasis Rev 9: 353-367, 1990.
29. Liotta LA, Goldfarb RH, Brundage R, Seigal GP, Terranova V and Gabrisan S: Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 41: 4629-4636, 1981.
30. Salo T, Liotta LA, Keski-Oja J, Turpeenniemi-Hujanen T and Tryggvason K: Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells - role in metastases. Int J Cancer 30: 669-673, 1982.
31. Arnoletti JP, Albo D, Granick MS, Solomon MP, Castiglioni A, Rothman VL and Tuszynski GP: Thrombospondin and transforming growth factor-β1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells. Cancer 76: 998-1005, 1995.
32. Ellis V, Pyke C, Eriksen J, Solberg H and Danø K: The urokinase receptor: involvement in cell surface proteolysis and cancer invasion. Ann NY Acad Sci 667: 13-31, 1992.
33. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogcne. Science 235: 117-182, 1987.
34. Paik S, Hazan R, Fisher ER, Sass RE, Fisher B, Redmond C, Schlessinger J, Lippman ME and King CR: Pathologic findings from the national surgical adjuvant breast and bowel project: prognostic significance of erbB2 protein overexpression in primary breast cancer. J Clin Oncol 8: 103-112, 1990.
35. Rose DP, Connolly JM and Liu X-H: Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice, and the invasive capacity of these cell lines in vitro. Cancer Res 54: 6557-6562, 1994.
36. Zhau HYE, Zhou J, Symmans WF, Chen B-Q, Chang S-M, Sikes RA and Chung LWK: Transfected neu oncogene induces human prostate cancer metastasis. Prostate 28: 73-83, 1996.
37. Liu Y, El-Ashry D, Chen D, Ding IYF and Kern FG: MCF-7 breast cancer cells overexpressing transfected c-erbB2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivity in vivo. Breast Cancer Res Treat 34: 97-117, 1995.